Clinical Trial Update: Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED) [Phase 2]

View source ↗

Summary

A Phase II trial of temozolomide in newly diagnosed glioblastoma has completed; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2009-03-12